Cenexi

Cenexi, established in 2003, is a prominent European pharmaceutical manufacturing company with specialized expertise in drug product manufacturing, particularly for sterile oncology products. Operating across France and Belgium, Cenexi leverages state-of-the-art technologies to deliver comprehensive pharmaceutical production services. The company serves both business-to-business and business-to-consumer markets, emphasizing innovation in its manufacturing processes. With a history rooted in quality and advanced capabilities, Cenexi has positioned itself as a key player in the European healthcare sector.

The company offers a broad spectrum of services, including contract development and manufacturing for various dosage forms such as vials, bottles, and liquids. Cenexi operates multiple advanced facilities, ensuring rigorous quality control and adherence to stringent regulatory standards. Employing between 1,000-5,000 individuals across its 6 locations, the company maintains a significant operational footprint. To understand the driving force behind these operations, you can Meet Cenexi's team. Their commitment to excellence underpins the company's ability to handle complex pharmaceutical production challenges.

Cenexi's strategic focus on sterile oncology products highlights its specialized niche within the pharmaceutical industry. The company's dedication to innovation is evident in its continuous investment in advanced manufacturing technologies and quality assurance systems. This commitment ensures the reliable production of critical medications. With a revenue of $246.2M, Cenexi demonstrates substantial market presence and operational capacity. Its integrated approach, from development to logistics, supports clients in bringing vital pharmaceutical products to market efficiently and safely.